Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation
Publication date
2005
Authors
van Geffen, E.C.G.
Hugtenburg, J.G.
Heerdink, Rob
van Hulten, R
Egberts, Toine
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Keywords
Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health, SDG 3 - Good Health and Well-being
Citation
van Geffen, E C G, Hugtenburg, J G, Heerdink, E R, Van Hulten, R P & Egberts, A C G 2005, 'Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation', European Journal of Clinical Pharmacology, vol. 61, pp. 303-307.